Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study

Roy O. Mathew, Mandeep S. Sidhu, Charanjit S. Rihal, Ryan Lennon, Mohammed El-Hajjar, Neil Yager, Radmila Lyubarova, Khaled Abdul-Nour, Steven Weitz, D. Fearghas O’Cochlain, Vishakantha Murthy, Justin Levisay, Kevin Marzo, John Graham, Vlad Dzavik, Derek So, Shaun Goodman, Yves D. Rosenberg, Naveen Pereira, Michael E. Farkouh

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study'. Together they form a unique fingerprint.

Medicine & Life Sciences